Clinical Trials List
2023-03-01 - 2027-04-30
Phase III
Recruiting10
ICD-10I25.10
Atherosclerotic heart disease of native coronary artery without angina pectoris
ICD-9429.2
Cardiovascular disease, unspecified
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 傅家保 Division of Endocrinology
- 李宇璇 Division of Endocrinology
- WEI-WEN LIN Division of Endocrinology
- 蔡易婷 Division of Endocrinology
- Yu-Cheng Hsieh Division of Endocrinology
- 林時逸 Division of Geriatrics
- 李佳霖 醫學研究部
- 張之昀 Division of Endocrinology
- 王奇彥 Division of Cardiovascular Diseases
- I-TE LEE Division of Endocrinology
- 沈宜靜 Division of Endocrinology
- 鄭由承 Division of Endocrinology
- 鄭諭聰 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- CHO-KAI WU Division of General Internal Medicine
- MAO-HSIN LIN Division of General Internal Medicine
- Juey-Jen Hwang Division of General Internal Medicine
- JEN-KUANG LEE Division of General Internal Medicine
- 林柏志 Division of General Internal Medicine
- YEN-HUNG LIN Division of General Internal Medicine
- 陳盈憲 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 洪大川 Division of Cardiovascular Diseases
- 陳俊延 Division of Cardiovascular Diseases
- 林書毅 Division of Cardiovascular Diseases
- 洪崇烈 Division of Cardiovascular Diseases
- 劉俊傑 Division of Cardiovascular Diseases
- 程崇偉 Division of Cardiovascular Diseases
- 陳律安 Division of Cardiovascular Diseases
- 蘇正煌 Division of Cardiovascular Diseases
- 李俊偉 Division of Cardiovascular Diseases
- 簡禎彥 Division of Cardiovascular Diseases
- 郭任遠 Division of Cardiovascular Diseases
- 李應湘 Division of Cardiovascular Diseases
- 廖峰慶 Division of Cardiovascular Diseases
- 林肇鋒 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Cheng-Han Lee Division of General Internal Medicine
- 陳柏偉 Division of General Internal Medicine
- Shih-Hung Chan Division of General Internal Medicine
- 李文煌 Division of General Internal Medicine
- Po-Sheng Chen Division of General Internal Medicine
- 黃鼎鈞 Division of General Internal Medicine
- 張獻元 Division of General Internal Medicine
- 黃睦翔 Division of General Internal Medicine
- Po-Tseng Lee Division of General Internal Medicine
- Ju-Yi Chen Division of General Internal Medicine
- 柯呈諭 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 張懷仁 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳韋璁 Division of Cardiovascular Diseases
- Po-Chao Hsu Division of Cardiovascular Diseases
- Chun-Yuan Chu Division of Cardiovascular Diseases
- Ye-Hsu Lu Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
75 participants
-
Global
6000 participants
